F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice

Neuroscience

Volumn 223, Issue , 2012, Pages 465-472

  Hafez, D M ^a   Huang, J Y ^b   Richardson, J C ^c   Masliah, E ^d,e   Peterson, D A ^a   Marr, R A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; F spondin; Gene therapy; Reelin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; F SPONDIN; LENTIVIRUS VECTOR; PROTEIN; REELIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; EXPERIMENTAL TEST; FEMALE; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MENTAL TASK; MORRIS WATER MAZE; MOUSE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TASK PERFORMANCE; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; EXTRACELLULAR MATRIX PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS; PRESENILIN-1;

EID: 84866483826     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.038     Document Type: Article

References (50)

1. Andrade N., Komnenovic V., Blake S.M., Jossin Y., Howell B., Goffinet A., Schneider W.J., Nimpf J. ApoER2/VLDL receptor and Dab1 in the rostral migratory stream function in postnatal neuronal migration independently of Reelin. Proc Nat Acad Sci U S A 2007, 104:8508-8513.
2. Ashford J.W. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 2004, 23:157-165.
3. Assadi A.H., Zhang G., Beffert U., McNeil R.S., Renfro A.L., Niu S., Quattrocchi C.C., Antalffy B.A., Sheldon M., Armstrong D.D., Wynshaw-Boris A., Herz J., D'Arcangelo G., Clark G.D. Interaction of reelin signaling and Lis1 in brain development. Nat Genet 2003, 35:270-276.
4. Beffert U., Morfini G., Bock H.H., Reyna H., Brady S.T., Herz J. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 2002, 277:49958-49964.
5. Brosda J., Dietz F., Koch M. Impairment of cognitive performance after reelin knockdown in the medial prefrontal cortex of pubertal or adult rats. Neurobiol Dis 2011, 44:239-247.
6. Burstyn-Cohen T., Tzarfaty V., Frumkin A., Feinstein Y., Stoeckli E., Klar A. F-Spondin is required for accurate pathfinding of commissural axons at the floor plate. Neuron 1999, 23:233-246.
7. Caviness V.S. Neocortical histogenesis in normal and reeler mice: a developmental study based upon [3H]thymidine autoradiography. Brain Res 1982, 256:293-302.
8. Caviness V.S., Sidman R.L. Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice. an autoradiographic analysis. J Comp Neurol 1973, 148:141-151.
9. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci 2007, 27:2727-2733.
10. Courtes S., Vernerey J., Pujadas L., Magalon K., Cremer H., Soriano E., Durbec P., Cayre M. Reelin controls progenitor cell migration in the healthy and pathological adult mouse brain. PLoS ONE 2011, 6:e20430.
11. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24:471-479.
12. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
13. Dodart J.C., Mathis C., Bales K.R., Paul S.M. Does my mouse have Alzheimer's disease?. Genes Brain Behav 2002, 1:142-155.
14. Durakoglugil M.S., Chen Y., White C.L., Kavalali E.T., Herz J. Reelin signaling antagonizes beta-amyloid at the synapse. Proc Nat Acad Sci U S A 2009, 106:15938-15943.
15. Feinstein Y., Borrell V., Garcia C., Burstyn-Cohen T., Tzarfaty V., Frumkin A., Nose A., Okamoto H., Higashijima S., Soriano E., Klar A. F-spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons. Development (Cambridge, England) 1999, 126:3637-3648.
16. Gong C., Wang T.W., Huang H.S., Parent J.M. Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus. J Neurosci 2007, 27:1803-1811.
17. Hafez D., Huang J.Y., Huynh A.M., Valtierra S., Rockenstein E., Bruno A.M., Lu B., DesGroseillers L., Masliah E., Marr R.A. Neprilysin-2 is an important beta-amyloid degrading enzyme. Am J Pathol 2011, 178:306-312.
18. Heinrich C., Nitta N., Flubacher A., Muller M., Fahrner A., Kirsch M., Freiman T., Suzuki F., Depaulis A., Frotscher M., Haas C.A. Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J Neurosci 2006, 26:4701-4713.
19. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev 2006, 7:850-859.
20. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., Herz J. Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24:481-489.
21. Higashijima S., Nose A., Eguchi G., Hotta Y., Okamoto H. Mindin/F-spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev Biol 1997, 192:211-227.
22. Ho A., Sudhof T.C. Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Nat Acad Sci U S A 2004, 101:2548-2553.
23. Hoe H.S., Freeman J., Rebeck G.W. Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons. Mol Neurodegener 2006, 1:18.
24. Hoe H.S., Harris D.C., Rebeck G.W. Multiple pathways of apolipoprotein E signaling in primary neurons. J Neurochem 2005, 93:145-155.
25. Hoe H.S., Lee K.J., Carney R.S., Lee J., Markova A., Lee J.Y., Howell B.W., Hyman B.T., Pak D.T., Bu G., Rebeck G.W. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 2009, 29:7459-7473.
26. Hoe H.S., Wessner D., Beffert U., Becker A.G., Matsuoka Y., Rebeck G.W. F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Mol Cell Biol 2005, 25:9259-9268.
27. Howlett D.R., Bowler K., Soden P.E., Riddell D., Davis J.B., Richardson J.C., Burbidge S.A., Gonzalez M.I., Irving E.A., Lawman A., Miglio G., Dawson E.L., Howlett E.R., Hussain I. Abeta deposition and related pathology in an APP×PS1 transgenic mouse model of Alzheimer's disease. Histol Histopathol 2008, 23:67-76.
28. Howlett D.R., Richardson J.C., Austin A., Parsons A.A., Bate S.T., Davies D.C., Gonzalez M.I. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 2004, 1017:130-136.
29. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., Gerard C., Hama E., Lee H.J., Saido T.C. Metabolic regulation of brain Abeta by neprilysin. Science (New York, NY) 2001, 292:1550-1552.
30. Knuesel I., Nyffeler M., Mormede C., Muhia M., Meyer U., Pietropaolo S., Yee B.K., Pryce C.R., LaFerla F.M., Marighetto A., Feldon J. Age-related accumulation of reelin in amyloid-like deposits. Neurobiol Aging 2009, 30:697-716.
31. Kocherhans S., Madhusudan A., Doehner J., Breu K.S., Nitsch R.M., Fritschy J.M., Knuesel I. Reduced reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci 2010, 30:9228-9240.
32. Kramer P.L., Xu H., Woltjer R.L., Westaway S.K., Clark D., Erten-Lyons D., Kaye J.A., Welsh-Bohmer K.A., Troncoso J.C., Markesbery W.R., Petersen R.C., Turner R.S., Kukull W.A., Bennett D.A., Galasko D., Morris J.C., Ott J. Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study. Neurobiol Aging 2011, 32:2113-2122.
33. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 2003, 23:1992-1996.
34. Niu S., Renfro A., Quattrocchi C.C., Sheldon M., D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 2004, 41:71-84.
35. Niu S., Yabut O., D'Arcangelo G. The reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci 2008, 28:10339-10348.
36. Ohkubo N., Lee Y.D., Morishima A., Terashima T., Kikkawa S., Tohyama M., Sakanaka M., Tanaka J., Maeda N., Vitek M.P., Mitsuda N. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J 2003, 17:295-297.
37. Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
38. Ringman J.M., Coppola G., Elashoff D., Rodriguez-Agudelo Y., Medina L.D., Gylys K., Cummings J.L., Cole G.M. Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease. Dement Geriatr Cogn Disord 2012, 33:1-5.
39. Ringman J.M., Schulman H., Becker C., Jones T., Bai Y., Immermann F., Cole G., Sokolow S., Gylys K., Geschwind D.H., Cummings J.L., Wan H.I. Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Arch Neurol 2012, 69:96-104.
40. Rockenstein E., Mallory M., Mante M., Sisk A., Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 2001, 66:573-582.
41. Rogers J.T., Rusiana I., Trotter J., Zhao L., Donaldson E., Pak D.T., Babus L.W., Peters M., Banko J.L., Chavis P., Rebeck G.W., Hoe H.S., Weeber E.J. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learn Mem 2011, 18:558-564.
42. Seripa D., Matera M.G., Franceschi M., Daniele A., Bizzarro A., Rinaldi M., Panza F., Fazio V.M., Gravina C., D'Onofrio G., Solfrizzi V., Masullo C., Pilotto A. The RELN locus in Alzheimer's disease. J Alzheimers Dis 2008, 14:335-344.
43. Singer O., Marr R.A., Rockenstein E., Crews L., Coufal N.G., Gage F.H., Verma I.M., Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 2005, 8:1343-1349.
44. Spencer B., Marr R.A., Rockenstein E., Crews L., Adame A., Potkar R., Patrick C., Gage F.H., Verma I.M., Masliah E. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci 2008, 9:109.
45. Strickland D.K., Kounnas M.Z., Argraves W.S. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995, 9:890-898.
46. Teixeira C.M., Martin E.D., Sahun I., Masachs N., Pujadas L., Corvelo A., Bosch C., Rossi D., Martinez A., Maldonado R., Dierssen M., Soriano E. Overexpression of reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder. Neuropsychopharmacology 2011, 36:2395-2405.
47. Tiscornia G., Singer O., Verma I.M. Production and purification of lentiviral vectors. Nat Protoc 2006, 1:241-245.
48. Ventruti A., Kazdoba T.M., Niu S., D'Arcangelo G. Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain. Neuroscience 2011, 189:32-42.
49. Wallace V.A. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 1999, 9:445-448.
50. Zhang J., Goodlett D.R., Quinn J.F., Peskind E., Kaye J.A., Zhou Y., Pan C., Yi E., Eng J., Wang Q., Aebersold R.H., Montine T.J. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis 2005, 7:125-133. discussion 173-180.